Internalization and -arrestin recruitment assays were performed by Eurofins Discovery (Fremont, CA, USA)
DISCLAIMER: These statements have not been approved by the Food and Drug Administration
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are being used increasingly for the management of type 2 diabetes mellitus (T2DM) or obesity because of their association with robust glucose lowering, weight loss, and cardiorenal benefits
JAMA Neurol 2014
New studies show that GLP-1s can lower inflammation in the body, which may also help manage cardiovascular disease
Contact your healthcare provider immediately if you experience severe persistent abdominal pain, inability to pass gas or have bowel movements, persistent vomiting, blood in stool, fever with gastrointestinal symptoms, or signs of dehydration